Calcitonin receptor mRNA in mononuclear leucocytes from postmenopausal women: decrease during osteoporosis and link...

Area of Science:

• Endocrinology
• Bone Biology
• Molecular Biology

Background:

• Calcitonin regulates bone resorption through its receptor (CTR) on osteoclasts.
• Two human calcitonin receptor (hCTR) isoforms, hCTR1 and hCTR2, exhibit distinct structures and signaling pathways.
• Understanding hCTR's role in menopause and osteoporosis is crucial for bone health research.

Purpose of the Study:

• To investigate the association between specific hCTR isoforms, total hCTR mRNA levels, and high bone resorption/turnover in postmenopausal osteoporosis.
• To compare hCTR expression and bone turnover markers across premenopausal, healthy postmenopausal, and osteoporotic postmenopausal women.

Main Methods:

• Reverse-transcriptase polymerase chain reaction (RT-PCR) was used to assess hCTR mRNA (hCTR1 and hCTR2) in mononuclear blood cells.
• Semiquantitative analysis of total hCTR mRNA was performed.
• Bone turnover markers including serum calcitonin, urinary deoxypyridinoline (D-Pyr), serum bone alkaline phosphatase (SBAP), and osteocalcin (SOC) were measured.

Main Results:

• Healthy postmenopausal women and osteoporotic patients expressing hCTR2 exhibited significantly lower bone turnover markers compared to those without hCTR2.
• Total hCTR mRNA levels were comparable between premenopausal and healthy postmenopausal women.
• Osteoporotic postmenopausal women showed markedly lower total hCTR mRNA levels than healthy postmenopausal women, with a negative correlation to bone turnover markers.

Conclusions:

• The presence of the hCTR2 isoform may be associated with reduced bone resorption in postmenopausal women.
• Significantly reduced total hCTR mRNA levels are linked to increased bone resorption and turnover in postmenopausal osteoporosis.
• Both specific hCTR isoforms and quantitative changes in total hCTR mRNA are implicated in the pathophysiology of postmenopausal osteoporosis.